Literature DB >> 20095841

Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States.

Nila J Dharan, Larisa V Gubareva, Alexander I Klimov, Anthony E Fiore, Joseph S Bresee, Alicia M Fry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20095841     DOI： 10.1086/650178

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  9 in total

1.  The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.

Authors:  Wai Lan Wu; Siu-Ying Lau; Yixin Chen; Genyan Wang; Bobo Wing-Yee Mok; Xi Wen; Pui Wang; Wenjun Song; Tianwei Lin; Kwok-Hung Chan; Kwok-Yung Yuen; Honglin Chen
Journal:  Antiviral Res       Date:  2011-11-25       Impact factor: 5.970

2.  [Antivirals and pandemic flu].

Authors:  José María Eiros Bouza; Alberto Pérez Rubio; Javier Castrodeza Sanz
Journal:  Aten Primaria       Date:  2010-06-16       Impact factor: 1.137

Review 3.  Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies.

Authors:  Nancy Santesso; Jonathan Hsu; Reem Mustafa; Jan Brozek; Yao Long Chen; Jessica P Hopkins; Adrienne Cheung; Gayane Hovhannisyan; Liudmila Ivanova; Signe A Flottorp; Ingvil Saeterdal; Arthur D Wong; Jinhui Tian; Timothy M Uyeki; Elie A Akl; Pablo Alonso-Coello; Fiona Smaill; Holger J Schünemann
Journal:  Influenza Other Respir Viruses       Date:  2013-09       Impact factor: 4.380

4.  Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection.

Authors:  Shigeru Kohno; Muh-Yong Yen; Hee-Jin Cheong; Nobuo Hirotsu; Tadashi Ishida; Jun-ichi Kadota; Masashi Mizuguchi; Hiroshi Kida; Jingoro Shimada
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

Review 5.  Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.

Authors:  Jonathan Hsu; Nancy Santesso; Reem Mustafa; Jan Brozek; Yao Long Chen; Jessica P Hopkins; Adrienne Cheung; Gayane Hovhannisyan; Liudmila Ivanova; Signe A Flottorp; Ingvil Saeterdal; Arthur D Wong; Jinhui Tian; Timothy M Uyeki; Elie A Akl; Pablo Alonso-Coello; Fiona Smaill; Holger J Schünemann
Journal:  Ann Intern Med       Date:  2012-02-27       Impact factor: 25.391

6.  Combination Therapy Targeting Platelet Activation and Virus Replication Protects Mice against Lethal Influenza Pneumonia.

Authors:  Sivasami Pulavendran; Jennifer M Rudd; Prasanthi Maram; Paul G Thomas; Ramachandran Akhilesh; Jerry R Malayer; Vincent T K Chow; Narasaraju Teluguakula
Journal:  Am J Respir Cell Mol Biol       Date:  2019-12       Impact factor: 6.914

7.  Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14.

Authors:  Margaret Okomo-Adhiambo; Alicia M Fry; Su Su; Ha T Nguyen; Anwar Abd Elal; Elizabeth Negron; Julie Hand; Rebecca J Garten; John Barnes; Xu Xiyan; Julie M Villanueva; Larisa V Gubareva
Journal:  Emerg Infect Dis       Date:  2015-01       Impact factor: 6.883

8.  Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.

Authors:  Adam Meijer; Helena Rebelo-de-Andrade; Vanessa Correia; Terry Besselaar; Renu Drager-Dayal; Alicia Fry; Vicky Gregory; Larisa Gubareva; Tsutomu Kageyama; Angie Lackenby; Janice Lo; Takato Odagiri; Dmitriy Pereyaslov; Marilda M Siqueira; Emi Takashita; Masato Tashiro; Dayan Wang; Sun Wong; Wenqing Zhang; Rod S Daniels; Aeron C Hurt
Journal:  Antiviral Res       Date:  2014-07-17       Impact factor: 5.970

9.  Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.

Authors:  Emi Takashita; Adam Meijer; Angie Lackenby; Larisa Gubareva; Helena Rebelo-de-Andrade; Terry Besselaar; Alicia Fry; Vicky Gregory; Sook-Kwan Leang; Weijuan Huang; Janice Lo; Dmitriy Pereyaslov; Marilda M Siqueira; Dayan Wang; Gannon C Mak; Wenqing Zhang; Rod S Daniels; Aeron C Hurt; Masato Tashiro
Journal:  Antiviral Res       Date:  2015-02-23       Impact factor: 10.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.